← Back to headlines
Biogen Stock Could Rise on Positive Drug Trial Data
Truist Securities suggests that shares of biotechnology company Biogen could see an increase if the company releases positive results from its recent trials for kidney and Alzheimer's treatments.
13 Jul, 13:03 — 13 Jul, 13:03
